Clinical Trial

Analgesic Effect of Accelerated Repetitive Transcranial Magnetic Stimulation in Neuropathic Pain

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 10, 2024 (before its estimated March 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
Peripheral neuropathy is a frequent condition, commonly associated with pain. Repetitive Transcranial Magnetic Stimulation (rTMS) is a noninvasive method of modulation of brain plasticity and is regarded as one of alternative methods to alleviate pain associated with various kind of neuropathies. rTMS is usually performed once a day and the whole therapy of neuropathic pain lasts one week. In a number of recent clinical trials including patients with depression and some other disorders, rTMS was delivered several times a day, which reduced the time of the whole therapy. This approach was termed an accelerated rTMS. The purpose of this study is to investigate feasibility of accelerated rTMS in treatment of neuropathic pain.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-03-16; most recent amendment 2024-10-09.
Status change: Not Yet Recruiting → Recruiting 2022-11-04
Trial Details
NCT Number NCT05295498
Lead Sponsor Jakub Antczak
Conditions Peripheral Neuropathy
Enrollment 70 participants
Start Date 2022-11-04
Primary Completion 2026-03-31 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2024-10-10